alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack, Chief Justice

David F. Viviano,

Chief Justice Pro Tem

Stephen J. Markman

Brian K. Zahra

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh,

Justices

Order 

March 22, 2019

158854

SC: 158854

In re I.M. LONG, Minor. COA: 344326

Oakland CC Family Division:

2017-849503-NA

_______________________________________/

On order of the Court, the application for leave to appeal the November 20, 2018 

judgment of the Court of Appeals is considered. We direct the Clerk to schedule oral 

argument on the application. MCR 7.305(H)(1). 

The petitioner-appellant shall file a supplemental brief within 42 days of the date 

of this order addressing: (1) whether the Court of Appeals clearly erred in reversing the 

trial court’s decision to exercise jurisdiction over the minor child pursuant to MCL 

712A.2(b)(2), where the child was living with a guardian and there was no evidence that 

the guardian’s home was unfit, yet there was evidence that the respondent-father is 

incarcerated and had a history of criminal conduct; (2) whether the Court of Appeals 

clearly erred in reversing the trial court’s additional decision to exercise jurisdiction over 

the minor child pursuant to MCL 712A.2(b)(6), based on the respondent-father’s conduct 

in the two years preceding the filing of the petition when he was a putative, not legal, 

father; and (3) whether the trial court’s reliance on In re LE, 278 Mich App 1 (2008), was 

misplaced. In addition to the brief, the petitioner-appellant shall electronically file an 

appendix conforming to MCR 7.312(D)(2). In the brief, citations to the record must 

provide the appendix page numbers as required by MCR 7.312(B)(1). The respondentappellee shall file a supplemental brief within 21 days of being served with the petitionerappellant’s brief. The respondent-appellee shall also electronically file an appendix, or in 

the alternative, stipulate to the use of the appendix filed by the petitioner-appellant. The 

lawyer-guardian ad litem for the minor child is invited to file a supplemental brief within 

21 days of being served with the petitioner-appellant’s brief. A reply, if any, must be 

filed by the petitioner-appellant within 14 days of being served with the respondentappellee’s brief. The parties should not submit mere restatements of their application 

papers.
I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 March 22, 2019 

s0319

2

Clerk

The Children’s Law and Family Law Sections of the State Bar of Michigan, the 

UDM Juvenile Appellate Practice Clinic, and the University of Michigan Law School 

Child Advocacy Law Clinic are invited to file briefs amicus curiae. Other persons or 

groups interested in the determination of the issues presented in this case may move the 

Court for permission to file briefs amicus curiae.
§ 800.801 Obligation of parties to provide information. ( a ) Parties to a transaction that is notified or declared under subparts D or E, or a transaction for which no notice or declaration has been submitted and for which the Staff Chairperson has requested information to assess whether the transaction is a covered transaction, shall provide information to the Staff Chairperson that will enable the Committee to conduct a full assessment, review, and/or investigation of the transaction. Parties to a transaction that have filed information with the Committee shall promptly advise the Staff Chairperson of any material changes to such information. If deemed necessary by the Committee, information may be obtained from parties to a transaction or other persons through subpoena or otherwise, under the Defense Production Act Reauthorization of 2003, as amended (50 U.S.C. 4555(a)).
( b ) Documentary materials or information required or requested to be filed with the Committee under this part shall be submitted in English. Supplementary materials, such as annual reports, written in a foreign language shall be submitted in certified English translation.
( c ) Any information filed with the Committee in connection with any action for which a report is required under section 721(l)(6)(B) with respect to the implementation of a mitigation agreement or condition described in section 721(l)(3)(A) shall be accompanied by a certification that complies with the requirements of section 721(n) and § 800.204. A sample certification may be found at the Committee's section of the Department of the Treasury website.
HomeGlobal Social Media Presence...Department of State Social Media Sites: Domestic Accounts

# 									Department of State Social Media Sites: Domestic Accounts							

## 								Domestic Social Media Sites							

        - Administration (A)
        - Arms Control, Verification, and Compliance (AVC)
        - Consular Affairs (CA)
        - Conflict and Stabilization Operations (CSO)
        - Counterterrorism (CT)
        - Democracy, Human Rights, and Labor (DRL)
        - Diplomatic Security (DS)
        - Under Secretary for Economic Growth, Energy, and the Environment (E)
        - Economic and Business Affairs (EB)
        - Educational and Cultural Affairs (ECA)
        - Energy Resources (ENR)
        - Foreign Assistance (F)
        - Foreign Service Institute (FSI)
        - Global Engagement Center (GEC)
        - Global Public Affairs (GPA)
        - Global Talent Management (GTM)
        - Legislative Affairs (H)
        - International Narcotics and Law Enforcement Affairs (INL)
        - International Religious Freedom (IRF)
        - Information Resource Management (IRM)
        - International Security and Nonproliferation (ISN)
        - Under Secretary for Civilian Security, Democracy, and Human Rights (J)
        - Under Secretary for Management (M)
        - Medical Services (MED)
        - Overseas Building Operations (OBO)
        - Oceans and International Environmental and Scientific Affairs (OES)
        - Under Secretary for Political Affairs (P)
        - Political-Military Affairs (PM)
        - Population, Refugees, and Migration (PRM)
        - Under Secretary for Public Diplomacy and Public Affairs (R)
        - The Secretary (S)
        - Under Secretary for Arms Control and International Security (T)

Tags

Bureau of Global Public AffairsPublic Diplomacy

Back to Top
# United Arab Emirates

253 items

        -    Media Note  		Assistant Secretary Leaf’s Travel to the Middle East	  November 14, 2023 
        -    Media Note  		Joint Statement Between the Governments of the United States and the United Arab Emirates on the Tenth Economic Policy Dialogue	  November 1, 2023 
        -    Media Note  		Special Presidential Envoy for Climate Kerry’s Travel to Saudi Arabia and United Arab Emirates	  October 27, 2023 
        -    Media Note  		Assistant Secretary Leaf’s Travel to the Middle East	  October 25, 2023 
        -    Readout  		Secretary Blinken’s Meeting with Foreign Ministers from the Middle East	  October 24, 2023 
        -    Interview  		Secretary Antony J. Blinken With Kristen Welker of NBC’s Meet the Press	  Antony J. BlinkenOctober 22, 2023Benjamin Franklin RoomWashington, D.C. 
        -    Overseas Schools Fact Sheet  		Dubai, UAE: American School of Dubai: 2023-2024 Fact Sheet	  October 19, 2023 
        -    Readout  		Secretary Blinken’s Meeting with UAE President Sheikh Mohammed bin Zayed Al Nahyan	  October 14, 2023 
        -    Press Statement  		Secretary Blinken’s Travel to Israel, Jordan, Qatar, Bahrain, Saudi Arabia, the United Arab Emirates, and Egypt 	  Matthew MillerOctober 12, 2023 
        -    		Travel to Israel, Jordan , Qatar, Bahrain, Saudi Arabia, the United Arab Emirates, and Egypt, October 11-18, 2023	   

previous page123456…26next page

Back to Top
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane l una ni m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T AL B E R T R E P E L I T A MAMB OU , P et i t i on er , v. E R I C H . H O L D E R , J r ., A tto rn e yG e n e r a l, R e s p o n d e n t. N o. 08- 70557 A ge nc yN o. A 078- 020- 321 ME MOR AN DU M *

O n P e t i t i on f

orR e vi e w of

a n O r de rof

the B o ar do f I m m ig r a tio n A p p e a ls S ubm i tt e d Jul y19, 2010 ** B efo re: B . F L E T C H E R , R E IN H A R D T an dW A R D L A W , C i rcu i tJu d g es. A l be rtR e pe l i t aM a m bou, ana t i ve a nd c i t i z e n of I ndone s i a , pe t i t i ons f

or r e v ie w o f

th e B o ar do f

I m m ig r a tio n A p p e a ls ’ ( “B I A ” ) o r d e rd e n y in g h is m o tio n to reco n si d er. O u r j u ri sd i ct i o n i s g o v ern edb y 8 U . S . C . § 1 2 5 2 . W e rev i ew fo r ab u se o f d is c r e tio n th e d e n ia l o f am o tio n to r e c o n s id e r , L a ra - T o rr es v . A s h c r o

ft , 383 

# FI LED JU L 29 2010 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS08- 70557 2 F . 3d 968, 972 ( 9th C i r . 2004) , a nd w e de nyi n parta nd di s m i s s i n partthe pe t i t i on f o rr e v i e w. T h e B I A d idn o t ab u s e its d is c r e tio n in d e n y in g M am b o u ’s m o tio n to r e c ons i de rbe c aus e the m ot i on f a i l e d t o i de nt i f

ya nye rr orof

l aw orf a c ti n the B I A ’s O c to b e r1 3 , 2 0 0 7 , o r d e rd is m is s in g h is ap p e a l. See 8 C . F . R . § 1 00 3. 2(b)(1); s e e a l s o So c o p - G o n z a lezv . I

NS , 27 2 F . 3d 11 76 , 11 80 n. 2 (9th C i r. 20 01 ) ( en banc) (purpo se of a m ot i on t o rec on si der i s “ t o d em on strat e thatthe IJor the B IA erre d as a m att erof l aw or fa ct . ”) . T o the ext entM am bo u chal l enges the B IA ’ s O ct ob er30 , 20 07 , order d is m is s in g h is ap p e a l f

r o m th e im m ig r a tio n ju d g e ’s d e c is io n d e n y in g h is w i thhol di ng of

r e m ova l appl i c a t i on, w e l a c k j ur i s di c t i on be c aus e thi s pe t i t i on f or r e v ie w is n o t tim e lya s to th a t o r d e r . Se e S i n gh v . I NS , 3 1 5 F .3 d1 1 8 6 , 1 1 8 8 ( 9 th C i r. 20 03 ). P E T IT IO N F O R R E V IE W D E N IE D i n p art; D IS M IS S E D i n p art.
§ 403.220 Supplemental Health Insurance Panel. ( a ) *Membership.* The Supplemental Health Insurance Panel (Panel) consists of— ( 1 ) The Secretary or a designee, who serves as chairperson, and
( 2 ) Four State Commissioners or Superintendents of Insurance appointed by the President. (The terms Commissioner or Superintendent of Insurance include persons of similar rank.)
( b ) *Functions.* ( 1 ) The Panel determines whether or not a State regulatory program for Medicare supplemental health insurance policies meets and continues to meet minimum requirements specified in section 1882 of the Social Security Act.
( 2 ) The chairperson of the Panel informs the State Commissioners and Superintendents of Insurance of all determinations made under paragraph (b)(1) of this section.
§ 11.42 For which applicable clinical trials must clinical trial results information be submitted? ( a ) *Applicable clinical trials for which the studied product is approved, licensed, or cleared by FDA.* Unless a waiver of the requirement to submit clinical trial results information is granted in accordance with § 11.54, clinical trial results information must be submitted for any applicable clinical trial for which the studied product is approved, licensed, or cleared by FDA for which submission of clinical trial registration information is required in accordance with the following: ( 1 ) If the primary completion date is before January 18, 2017, the responsible party must submit the clinical trial results information specified in sections 402(j)(3)(C) and 402(j)(3)(I) of the Public Health Service Act (42 U.S.C. 282(j)(3)(C) and 42 U.S.C. 282(j)(3)(I)); or
( 2 ) If the primary completion date is on or after January 18, 2017, the responsible party must submit the clinical trial results information specified in § 11.48.
( b ) *Applicable clinical trials for which the studied product is not approved, licensed, or cleared by FDA.* Unless a waiver of the requirement to submit clinical trial results information is granted in accordance with § 11.54, clinical trial results information specified in § 11.48 must be submitted for any applicable clinical trial with a primary completion date on or after January 18, 2017 for which clinical trial registration information is required to be submitted and for which the studied product is not approved, licensed, or cleared by FDA.
EXHIBIT 32.1



CERTIFICATION OF CHIEF EXECUTIVE
OFFICER

pursuant to

18 U.S.C. SECTION 1350,

as adopted pursuant to

SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002





I, Manfred F. Dyck, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Hydromer, Inc. on
Form 10-K for the fiscal year ended June 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents in all material respects
the financial condition and results of operations of Hydromer, Inc.







|Date:
November 16, 2012 | Hydromer Inc.                                            
|----------------------- | ---------------------------------------------------------
|                        | By: /s/ Manfred F. Dyck                                  
|                        | Manfred F. Dyck Chairman and Chief
     Executive Officer
# Fiji

68 items

        -    Report  		2021 Report on International Religious Freedom: Fiji	  June 2, 2022 
        -    Bilateral Relations Fact Sheet  		U.S. Relations With Fiji	  June 2, 2022 
        -    Report  		2021 Country Reports on Human Rights Practices: Fiji	  April 12, 2022 
        -    Remarks  		Secretary Antony J. Blinken At a Meet and Greet with Mission Fiji Personnel and Families	  Antony J. BlinkenFebruary 12, 2022U.S. Embassy SuvaSuva, Fiji 
        -    Remarks  		Secretary Antony J. Blinken And Acting Fijian Prime Minister Aiyaz Sayed-Khaiyum At a Joint Press Availability	  Antony J. BlinkenFebruary 12, 2022Sofitel Fiji ResortDenarau Island, Fiji 
        -    Fact Sheet  		The United States-Fiji Relationship and Our Partnership for Peace, Stability, and Prosperity	  February 11, 2022 
        -    		Travel to Australia, Fiji, and Hawaii, February 7-13, 2022	   
        -    Press Statement  		Secretary Blinken to Travel to Australia, Fiji, and Hawaii	  Ned PriceFebruary 4, 2022 
        -    Press Statement  		Fiji National Day	  Antony J. BlinkenOctober 8, 2021 
        -    Report  		2021 Investment Climate Statements: Fiji	  July 21, 2021 

previous page1234567next page

Back to Top
TherapeuticsMD, Inc. 10-K


Exhibit
10.16

 


AMENDMENT TO WARRANT


 


 


This Amendment to Warrant
(this “Amendment”) is dated as of February 20, 2021 by and between John C.K. Milligan, IV (“Holder”)
and TherapeuticsMD, Inc. (“Company”).


 


Recitals


 


WHEREAS, in connection
with the guaranty by Holder of a line of credit issued by 1st United Bank to vitaMedMD, LLC, a Delaware limited liability
company and wholly owned subsidiary of the Company on March 6, 2011, Company issued to Holder that certain Warrant No. 2 dated
as of October 4, 2011 granting Holder the right to purchase 204,571 shares of common stock, $0.001 par value per share, of the
Company (“Shares”) at a per Share price of $0.2444 (the “Warrant”).


 


WHEREAS, pursuant
to Section 11 of the Warrant, neither the Warrant nor any term thereof may be changed, waived, discharged or terminated without
the prior written consent of Holder and the Company.


WHEREAS, Company
and Holder wish to amend the Warrant in order to allow for a cashless exercise of the Warrant.


NOW, THEREFORE,
Company and Holder agree as follows:


1.       The
Warrant is hereby amended to add Sections 2(e) and 2(f), to read in their entirety as follows:


(e)       In
lieu of, or in addition to, exercising this Warrant as specified in subsection (a) above, Holder may from time to time convert
this Warrant, in whole or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares
or other securities otherwise issuable upon exercise of this Warrant minus the aggregate Purchase Price of such Shares by (b) the
fair market value of one Share. The fair market value of the Shares shall be determined pursuant to subsection (f) of this Section.


(f)       If
the Shares are traded regularly in a public market, the fair market value of the Shares shall be the closing price of the Shares
reported for the business day immediately before Holder delivers its completed Exercise Agreement to the Company. If the Shares
are not regularly traded in a public market, the Board of Directors of the Company shall determine fair market value in its reasonable
good faith judgment.


2.       Except
as amended hereby, the Warrant remains in full force and effect. This Amendment may be executed in two or more counterparts, each
of which shall be deemed an original, and both of which shall constitute one instrument.


	
        THERAPEUTICSMD, INC.

         

        By:_/s/ James C. D’Arecca_________________

        James C. D’Arecca

        Chief Financial
        Officer
	
        JOHN C.K. MILLIGAN, IV

         

        By: John C.K. Milligan, IV
§ 35.63 Report of and accounting for contributions. ( a ) Contributions of money accepted pursuant to § 35.62 (hereinafter referred to as “patient fund”) will be treated consistently with Federal deposit rules and as supplemented with appropriate procedures of the facility. This regulation is not intended to exclude contributions for the benefit of patients from proper accountability and control of funds and property.
( b ) Contributions of property accepted pursuant to § 35.62 shall be recorded and accounted for in the same manner as other property of a similar kind maintained in the hospital or station, but with suitable identification so that it can be distinguished from government-owned property.
HomeUkraine

# Ukraine

1741 items

        -    		Bureau of International Narcotics and Law Enforcement Affairs: Ukraine	   
        -    Report  		Ukraine	  July 19, 2018 
        -    Report  		Ukraine	  June 28, 2018 
        -    TIAS  		Ukraine (18-613) – Agreement Concerning Defense Cooperation	  June 13, 2018 
        -    Report  		Ukraine (Crimea)	  May 29, 2018 
        -    Report  		Ukraine	  May 29, 2018 
        -    Report  		Ukraine	  April 20, 2018 
        -    TIAS  		Ukraine (18-313) – Arrangement for the Exchange of Technical Information and Cooperation in Nuclear Safety Matters	  March 13, 2018 
        -    TIAS  		Ukraine (17-1206) – Extension to Agreement of December 4, 2006 on Scientific and Technological Cooperation	  December 6, 2017 
        -    Report  		Ukraine (Crimea)	  August 15, 2017 

previous page1…168169170171172…175next page

Back to Top
§ 50.21 Make available. ( a ) *General.* The requirement to make available coverage as provided in § 50.20 applies at the time an insurer makes the initial offer of coverage as well as at the time an insurer makes an initial offer of renewal of an existing policy.
( b ) *Offer consistent with definition of act of terrorism.* An insurer must make available coverage for insured losses in a policy of property and casualty insurance consistent with the definition of an act of terrorism as defined in § 50.4(b).
( c ) *Changes negotiated subsequent to initial offer.* If an insurer satisfies the requirement to make available coverage as described in § 50.20 by first making an offer with coverage for insured losses that does not differ materially from the terms, amounts, and other coverage limitations applicable to losses arising from events other than acts of terrorism, which the policyholder or prospective policyholder declines, the insurer may negotiate with the policyholder or prospective policyholder an option of partial coverage for insured losses at a lower amount of coverage if permitted by any applicable state law. An insurer is not required by the Act to offer partial coverage if the policyholder or prospective policyholder declines full coverage. See § 50.23.
( d ) *Demonstrations of compliance.* If an insurer makes an offer of insurance but no contract of insurance is concluded, the insurer may demonstrate that it has satisfied the requirement to make available coverage as described in § 50.20 through use of appropriate systems and normal business practices that demonstrate a practice of compliance.
#### § 594.313 United States.

The term *United States* means the United States, its territories and possessions, and all areas under the jurisdiction or authority thereof.
In-Person Attendees: The Portable Air Conditioners Test Procedures Meeting

Meeting Date: Wednesday, March 18, 2015

Name Title Organization Street City State Zip

Aloisi, Alberto Group Product Compliance 

and Regulatory Affairs 

Manager

DeLonghi Group Via L. Seitz, 47 Treviso N/A 31100

Armstrong, Ashley General Engineer U.S. Department of Energy (DOE) 1000 Independence 

Avenue, SW

Washington DC 20585-0121

Berringer, Bryan Lead Mechanical Engineer Department of Energy

(DOE)

Office of the Building Technologies Program

1000 Independence 

Avenue SW

Mailstop EE-2J

Washington DC 20585

Besant, Martin L. Product and Safety Engineer Electrolux Major Appliances North America 521 Chelsea Rd. Aberdeen MD 21001

Brookman, Douglas Facilitator Public Solutions, Inc. 108 Newburg Avenue Baltimore MD 21228

Butler, Sarah GC N/A N/A N/A N/A N/A

Chun Chun, Ni N/A Lawrence Berkeley National Laboratory (LBNL) One Cyclotron Road, 

MS:90R4000

University of California

Berkeley CA 94720-8136

Cleary, Jennifer Director, Regulatory Affairs Association of Home Appliance Manufacturers 

(AHAM)

1111 19th Street, NW,

Suite 402

Washington DC 20036

Crawford, Jim HVAC Regulatory Consultant N/A 713 WSW Loop 323, PMB 

123

Tyler TX 75701

Cymbalsky, John Supervisory Operations 

Research Analyst

U.S. Department of Energy (DOE) 1000 Independence 

Avenue, SW

Washington DC 20585

Dunham, Camila Program Manager Lawrence Berkeley National Laboratory (LBNL) One Cyclotron Road, Mail 

Stop: 90R4000

Berkeley CA 94720

Hodges, John Attorney at Law Wiley Rein 1776 K Street, NW Washington DC 20006

Lee, Sang Product Manager Denso Products and Sevices Americas, Inc. 3900 Via Oro Avenue Long Beach CA 90810

Mauer, Joanna Technical Advocacy 

Coordinator

Appliance Standards Awareness Project 

(ASAP)

529 14th Street NW,

Suite 600

Washington DC 20045

Prager, Mike Presidnet and CEO DeLonghi Group 2 Park Way & Route 17, 

South, Suite 3A

Upper Saddle 

River

NJ 07458

Reich, Judith Associate Director Navigant Consulting, Inc. 77 S. Bedford Street

Suite 400

Burlington MA 01803

Singerman, Nadav N/A Navigant Consulting, Inc. 1801 K Street, NW, Suite 

500

Washington DC 20006-1301

Vit, Stefano Regulatory Affairs and 

Standartization HVAC

DeLonghi Group Via L Seiltz 47 Treviso N/A 31100
In-Person Attendees: The Portable Air Conditioners Test Procedures Meeting

Meeting Date: Wednesday, March 18, 2015

Name Title Organization Street City State Zip

Watson, Troy Consultant Navigant Consulting, Inc. 1801 K Street, Suite 500 Washington DC 20006-1301